Mobile

LIMIT: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trial

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-005772-41

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The general aim of this study is to examine the tolerability and effectiveness of metformin treatment in patients with a recent TIA or minor ischemic stroke and impaired glucose tolerance. Primary outcomes will be the tolerability of metformin treatment (measured as number of patients still on treatment after 3 months), the safety of metformin treatment (which will be continuously monitored) and the adjusted difference in 2-hour post-load glucose levels at 3 months.

Critère d'inclusion

  • Patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke

Liens